IR, known as decreased insulin sensitivity, is known as the distinguishing feature of type 2 DM before the definitive diagnosis.[22] In the chronic process, IR is associated with metabolic disorders that cause poor cardiovascular outcomes such as hyperglycemia, HL, and HTN. This evidence concerns the gene INS and hypertensive disorder.